Logo Image
News
Media
Medical World NewsPodcastsVideosInsightsPeer ExchangeMedia DayNews NetworkRoundtablesShorts
Conference
Conference CoverageConference Listing
Publication
More
CME/CE
Partners
Resources
Interactive ToolsSpecial ProjectsSponsored
Contribute
Case StudiesWriters and Mentors
Clinical Forum Insights

Subscribe

  • News
  • Media
  • Conference
  • Publication
  • CME/CE
  • Partners
  • Resources
  • Contribute
  • Subscribe
  • Clinical Forum Insights
  • Antimicrobial Stewardship
  • Blood-Borne Diseases
    • Ebola
    • HCV / Hepatitis
  • Coronavirus / COVID
  • Food Borne Infection / Food Safety
    • E. Coli
    • Food Safety
    • Listeria
    • Salmonella
  • Fungal Infections
    • Candida auris
  • Gastrointestinal Infections
    • C. Difficile
    • H. Pylori
    • Norovirus
  • Healthcare Associated Infections (HAI)
  • Prevention
    • Antibiotics
    • Immunizations
    • Vaccines
  • Respiratory Infections
    • Community-Acquired Pneumonia
    • Measles
    • Influenza
  • Sexually Transmitted Diseases
    • HIV / AIDS
    • HPV
    • HSV
    • PrEP
  • Skin & Soft Tissue Diseases
    • MRSA
  • Zoonotic & Vector-Borne Diseases
    • Lyme Disease
    • ZIKA
Spotlight -
Vaccines in America|
Antibiotics Deconstructed|
Bench to Bedside With SIDP|
Antimicrobial Stewardship|
Hepatitis
Advertisement

Annie Antar, MD, PhD

Advertisement

Antar, MD, PhD is an assistant professor of medicine, Johns Hopkins University School of Medicine.

Articles by Annie Antar, MD, PhD

Does Slow Viral Clearance and Viral Rebound During Infection Contribute to Long COVID?

ByJohn Parkinson,Annie Antar, MD, PhD
March 9th 2025

Annie Antar, MD, PhD, offers insights around her research on her findings on this subject.

Advertisement

Latest Updated Articles

  • Does Slow Viral Clearance and Viral Rebound During Infection Contribute to Long COVID?
    Does Slow Viral Clearance and Viral Rebound During Infection Contribute to Long COVID?

    March 9th 2025



Advertisement
Advertisement

Trending on Contagion Live

1

FDA Approves Ensitrelvir as First Oral Post-Exposure Prevention Option for COVID-19

2

Migration Trends Demonstrate Rare, But Increasing Malaria Cases in New York City

3

Post-Exposure Protocol for STDs Prompts Resistant Gonorrhea

4

PolyPid Completes FDA NDA Submission for D-PLEX100 in Surgical Site Infection Prevention

5

Ciprofloxacin, Levofloxacin, and Moxifloxacin: A Clinical Comparison of Fluoroquinolone Safety and Use

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us